| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-9 |
GeneOrGeneProduct |
denotes |
Psoriasin |
| T2 |
10-80 |
DiseaseOrPhenotypicFeature |
denotes |
promotes invasion, aggregation and survival of pancreatic cancer cells |
| T3 |
82-93 |
DiseaseOrPhenotypicFeature |
denotes |
association |
| T4 |
99-118 |
DiseaseOrPhenotypicFeature |
denotes |
disease progression |
| T5 |
120-129 |
GeneOrGeneProduct |
denotes |
Psoriasin |
| T6 |
131-137 |
GeneOrGeneProduct |
denotes |
S100A7 |
| T7 |
158-165 |
ChemicalEntity |
denotes |
calcium |
| T8 |
206-215 |
DiseaseOrPhenotypicFeature |
denotes |
psoriatic |
| T9 |
216-220 |
DiseaseOrPhenotypicFeature |
denotes |
skin |
| T10 |
221-228 |
DiseaseOrPhenotypicFeature |
denotes |
lesions |
| T11 |
320-329 |
DiseaseOrPhenotypicFeature |
denotes |
functions |
| T12 |
340-353 |
DiseaseOrPhenotypicFeature |
denotes |
proliferation |
| T13 |
355-370 |
DiseaseOrPhenotypicFeature |
denotes |
differentiation |
| T14 |
372-381 |
DiseaseOrPhenotypicFeature |
denotes |
migration |
| T15 |
386-395 |
DiseaseOrPhenotypicFeature |
denotes |
apoptosis |
| T16 |
406-415 |
GeneOrGeneProduct |
denotes |
Psoriasin |
| T17 |
461-468 |
DiseaseOrPhenotypicFeature |
denotes |
cancers |
| T18 |
498-512 |
DiseaseOrPhenotypicFeature |
denotes |
poor prognosis |
| T19 |
546-555 |
GeneOrGeneProduct |
denotes |
Psoriasin |
| T20 |
559-576 |
DiseaseOrPhenotypicFeature |
denotes |
pancreatic cancer |
| T21 |
582-591 |
DiseaseOrPhenotypicFeature |
denotes |
functions |
| T22 |
615-626 |
DiseaseOrPhenotypicFeature |
denotes |
progression |
| T23 |
634-641 |
DiseaseOrPhenotypicFeature |
denotes |
disease |
| T24 |
657-666 |
GeneOrGeneProduct |
denotes |
Psoriasin |
| T25 |
697-715 |
DiseaseOrPhenotypicFeature |
denotes |
pancreatic tissues |
| T26 |
733-751 |
DiseaseOrPhenotypicFeature |
denotes |
pancreatic tumours |
| T27 |
760-798 |
DiseaseOrPhenotypicFeature |
denotes |
adjacent non-tumour pancreatic tissues |
| T28 |
800-809 |
GeneOrGeneProduct |
denotes |
Knockdown |
| T29 |
814-828 |
GeneOrGeneProduct |
denotes |
overexpression |
| T30 |
832-841 |
GeneOrGeneProduct |
denotes |
Psoriasin |
| T31 |
845-862 |
DiseaseOrPhenotypicFeature |
denotes |
pancreatic cancer |
| T32 |
863-868 |
CellLine |
denotes |
cells |
| T33 |
946-955 |
GeneOrGeneProduct |
denotes |
Psoriasin |
| T34 |
956-964 |
ChemicalEntity |
denotes |
ribozyme |
| T35 |
965-974 |
GeneOrGeneProduct |
denotes |
transgene |
| T36 |
994-999 |
OrganismTaxon |
denotes |
human |
| T37 |
1000-1009 |
GeneOrGeneProduct |
denotes |
Psoriasin |
| T38 |
1037-1046 |
GeneOrGeneProduct |
denotes |
knockdown |
| T39 |
1051-1065 |
GeneOrGeneProduct |
denotes |
overexpression |
| T40 |
1098-1104 |
ChemicalEntity |
denotes |
RT-PCR |
| T41 |
1109-1113 |
ChemicalEntity |
denotes |
qPCR |
| T42 |
1142-1151 |
GeneOrGeneProduct |
denotes |
Psoriasin |
| T43 |
1166-1183 |
DiseaseOrPhenotypicFeature |
denotes |
pancreatic cancer |
| T44 |
1249-1255 |
ChemicalEntity |
denotes |
assays |
| T45 |
1257-1262 |
DiseaseOrPhenotypicFeature |
denotes |
Local |
| T46 |
1263-1271 |
DiseaseOrPhenotypicFeature |
denotes |
invasive |
| T47 |
1272-1290 |
DiseaseOrPhenotypicFeature |
denotes |
pancreatic cancers |
| T48 |
1311-1319 |
DiseaseOrPhenotypicFeature |
denotes |
pancreas |
| T49 |
1320-1329 |
DiseaseOrPhenotypicFeature |
denotes |
expressed |
| T50 |
1347-1356 |
GeneOrGeneProduct |
denotes |
Psoriasin |
| T51 |
1357-1368 |
GeneOrGeneProduct |
denotes |
transcripts |
| T52 |
1387-1403 |
DiseaseOrPhenotypicFeature |
denotes |
cancers confined |
| T53 |
1421-1428 |
DiseaseOrPhenotypicFeature |
denotes |
Primary |
| T54 |
1442-1460 |
DiseaseOrPhenotypicFeature |
denotes |
distant metastases |
| T55 |
1495-1504 |
GeneOrGeneProduct |
denotes |
Psoriasin |
| T56 |
1506-1515 |
GeneOrGeneProduct |
denotes |
Psoriasin |
| T57 |
1531-1541 |
CellLine |
denotes |
cell lines |
| T58 |
1576-1582 |
DiseaseOrPhenotypicFeature |
denotes |
growth |
| T59 |
1587-1596 |
DiseaseOrPhenotypicFeature |
denotes |
migration |
| T60 |
1609-1616 |
ChemicalEntity |
denotes |
control |
| T61 |
1617-1622 |
CellLine |
denotes |
cells |
| T62 |
1707-1715 |
DiseaseOrPhenotypicFeature |
denotes |
invasion |
| T63 |
1742-1784 |
GeneOrGeneProduct |
denotes |
upregulation of matrix metalloproteinase-2 |
| T64 |
1786-1791 |
GeneOrGeneProduct |
denotes |
MMP-2 |
| T65 |
1797-1802 |
GeneOrGeneProduct |
denotes |
MMP-9 |
| T66 |
1804-1818 |
GeneOrGeneProduct |
denotes |
Overexpression |
| T67 |
1846-1857 |
DiseaseOrPhenotypicFeature |
denotes |
aggregation |
| T68 |
1862-1870 |
DiseaseOrPhenotypicFeature |
denotes |
survival |
| T69 |
1913-1922 |
DiseaseOrPhenotypicFeature |
denotes |
anchorage |
| T70 |
1991-2005 |
DiseaseOrPhenotypicFeature |
denotes |
local invasion |
| T71 |
2111-2131 |
DiseaseOrPhenotypicFeature |
denotes |
cell-matrix adhesion |
| T72 |
2164-2168 |
GeneOrGeneProduct |
denotes |
MMPs |
| T73 |
2231-2250 |
DiseaseOrPhenotypicFeature |
denotes |
disease progression |
| T74 |
2270-2288 |
ChemicalEntity |
denotes |
therapeutic target |
